Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
amouravfop alfa (IMM0306)
i
Other names:
IMM0306, IMM-0306, IMM 0306, IMC-002
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
ImmuneOnco Biopharma
Drug class:
CD20 inhibitor, CD47 inhibitor
Related drugs:
‹
rituximab (176)
obinutuzumab (68)
epcoritamab-bysp (11)
ofatumumab (8)
ublituximab-xiiy (7)
rituximab-pvvr (6)
rituximab-abbs (6)
rituximab/hyaluronidase (5)
Rixathon (rituximab biosimilar) (4)
EX103 (3)
ibritumomab tiuxetan (3)
IGM-2323 (2)
mosunetuzumab-axgb (2)
AR160 (2)
rituximab-arrx (2)
glofitamab-gxbm (1)
TQB2303 (rituximab biosimilar) (1)
IPH6501 (1)
odronextamab (1)
Ritucad (rituximab biosimilar) (1)
ACE1831 (0)
AcellBia (rituximab biosimilar) (0)
ACTR087 (0)
ALETA-001 (0)
ripertamab (0)
zuberitamab (0)
Avetux (rituximab biosimilar) (0)
B001 (0)
BAT4306F (0)
obinutuzumab-β (0)
BI 695500 (rituximab biosimilar) (0)
BM-ca (0)
CHO-H01 (0)
CIMAbior (rituximab biosimilar) (0)
CND261 (0)
DI Leu16 IL-2 (0)
IGN002 (0)
F007 (rituximab biosimilar) (0)
GB241 (rituximab biosimilar) (0)
GSK5926371 (0)
Halpryza (rituximab biosimilar) (0)
Hanlikon (rituximab biosimilar) (0)
Reditux (rituximab biosimilar) (0)
JHL1101 (rituximab biosimilar) (0)
JMT601 (0)
JNJ-8543 (0)
JS203 (0)
Kikuzubam (rituximab biosimilar) (0)
FBTA05 (0)
MabionCD20 (rituximab biosimilar) (0)
Mabtas (rituximab biosimilar) (0)
MK-8808 (rituximab biosimilar) (0)
MT-3724 (0)
NAV-006 (0)
Novex (rituximab biosimilar) (0)
AME-133v (0)
ocrelizumab (0)
XmAb13676 (0)
PRO131921 (0)
PRO-203 (0)
PSB202 (0)
Retuxira (rituximab biosimilar) (0)
TG20 (rituximab biosimilar) (0)
SAIT101 (rituximab biosimilar) (0)
SIBP-02 (rituximab biosimilar) (0)
TQB2825 (0)
TRU-015 (0)
veltuzumab (0)
ONO-7913 (8)
D3L-001 (7)
ALX148 (4)
ABBV-IMAB-TJC4 (2)
AK117 (2)
RRx-001 (2)
SRF231 (2)
VBI-003 (2)
YH38560 (2)
NI-2901 (1)
PT217 (1)
VBI-002 (1)
IMM2902 (1)
ADG153 (0)
anti-CD47 monoclonal antibody (0)
AO-176 (0)
AU7R-104 (0)
CC-90002 (0)
DSP-107 (0)
HCB101 (0)
HX-009 (0)
IMC002 (0)
IMC-201 (0)
IMM2505 (0)
IMM2520 (0)
ISB 1442 (0)
LB101 (0)
KJ-101 (0)
IBI188 (0)
TTI-622 (0)
NI-1801 (0)
NI-2601 (0)
PF-07901800 (0)
PF-07257876 (0)
6MW3211 (0)
SCR9168 (0)
SG1906 (0)
SG2501 (0)
IBI-322 (0)
SL-172154 (0)
PT886 (0)
TG-1801 (0)
Ti-061 (0)
IMM01 (0)
ZL-1201 (0)
rituximab (176)
obinutuzumab (68)
epcoritamab-bysp (11)
ofatumumab (8)
ublituximab-xiiy (7)
rituximab-pvvr (6)
rituximab-abbs (6)
rituximab/hyaluronidase (5)
Rixathon (rituximab biosimilar) (4)
EX103 (3)
ibritumomab tiuxetan (3)
IGM-2323 (2)
mosunetuzumab-axgb (2)
AR160 (2)
rituximab-arrx (2)
glofitamab-gxbm (1)
TQB2303 (rituximab biosimilar) (1)
IPH6501 (1)
odronextamab (1)
Ritucad (rituximab biosimilar) (1)
ACE1831 (0)
AcellBia (rituximab biosimilar) (0)
ACTR087 (0)
ALETA-001 (0)
ripertamab (0)
zuberitamab (0)
Avetux (rituximab biosimilar) (0)
B001 (0)
BAT4306F (0)
obinutuzumab-β (0)
BI 695500 (rituximab biosimilar) (0)
BM-ca (0)
CHO-H01 (0)
CIMAbior (rituximab biosimilar) (0)
CND261 (0)
DI Leu16 IL-2 (0)
IGN002 (0)
(0)
GB241 (rituximab biosimilar) (0)
GSK5926371 (0)
Halpryza (rituximab biosimilar) (0)
Hanlikon (rituximab biosimilar) (0)
Reditux (rituximab biosimilar) (0)
JHL1101 (rituximab biosimilar) (0)
JMT601 (0)
JNJ-8543 (0)
JS203 (0)
Kikuzubam (rituximab biosimilar) (0)
FBTA05 (0)
MabionCD20 (rituximab biosimilar) (0)
Mabtas (rituximab biosimilar) (0)
MK-8808 (rituximab biosimilar) (0)
MT-3724 (0)
NAV-006 (0)
Novex (rituximab biosimilar) (0)
AME-133v (0)
ocrelizumab (0)
XmAb13676 (0)
PRO131921 (0)
PRO-203 (0)
PSB202 (0)
Retuxira (rituximab biosimilar) (0)
TG20 (rituximab biosimilar) (0)
SAIT101 (rituximab biosimilar) (0)
SIBP-02 (rituximab biosimilar) (0)
TQB2825 (0)
TRU-015 (0)
veltuzumab (0)
ONO-7913 (8)
D3L-001 (7)
ALX148 (4)
ABBV-IMAB-TJC4 (2)
AK117 (2)
RRx-001 (2)
SRF231 (2)
VBI-003 (2)
YH38560 (2)
NI-2901 (1)
PT217 (1)
VBI-002 (1)
IMM2902 (1)
ADG153 (0)
anti-CD47 monoclonal antibody (0)
AO-176 (0)
AU7R-104 (0)
CC-90002 (0)
DSP-107 (0)
HCB101 (0)
HX-009 (0)
IMC002 (0)
IMC-201 (0)
IMM2505 (0)
IMM2520 (0)
ISB 1442 (0)
LB101 (0)
KJ-101 (0)
IBI188 (0)
TTI-622 (0)
NI-1801 (0)
NI-2601 (0)
PF-07901800 (0)
PF-07257876 (0)
6MW3211 (0)
SCR9168 (0)
SG1906 (0)
SG2501 (0)
IBI-322 (0)
SL-172154 (0)
PT886 (0)
TG-1801 (0)
Ti-061 (0)
IMM01 (0)
ZL-1201 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
CD20 positive
Follicular Lymphoma
CD20 positive
Follicular Lymphoma
IMM0306
Sensitive: C2 – Inclusion Criteria
IMM0306
Sensitive
:
C2
IMM0306
Sensitive: C2 – Inclusion Criteria
IMM0306
Sensitive
:
C2
CD20 positive
Marginal Zone Lymphoma
CD20 positive
Marginal Zone Lymphoma
IMM0306
Sensitive: C3 – Early Trials
IMM0306
Sensitive
:
C3
IMM0306
Sensitive: C3 – Early Trials
IMM0306
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.